Results 231 to 240 of about 23,640 (262)
Some of the next articles are maybe not open access.
The prevalence of severe asthma and severe eosinophilic asthma in Finland
Epidemiology, 2023Arja Viinanen +6 more
openaire +1 more source
Primary lysis of eosinophils in severe desquamative asthma
Clinical & Experimental Allergy, 2014SummaryPrimary lysis of eosinophils liberates free eosinophil granules (FEGs) releasing toxic proteins in association with bronchial epithelial injury repair. Eosinophil lysis may be significantly pathogenic. Bronchial mucosal FEGs are associated with uncontrolled asthma, severe asthma, aspirin‐sensitive asthma, and lethal asthma. FEGs in the bronchial
openaire +2 more sources
Eosinophils and T2 inflammation in severe asthma
Exploration of Asthma & AllergyAsthma is a common chronic inflammatory disease of the airways that affects more than 330 million people globally. Severe asthma, despite being 5–10% of the total asthmatic population presents significant morbidity and high cost due to health care utilization. The management of severe asthma has dramatically changed with the use of biologics.
Agamemnon Bakakos +2 more
openaire +1 more source
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
Chest, 2021Brian Kent +2 more
exaly
Eosinophilic and noneosinophilic asthma: Beyond severe asthma
2023Tara F. Carr, Sanjay B. Patel
openaire +1 more source
Emerging Therapies in Severe Eosinophilic Asthma
Archivos de Bronconeumología (English Edition), 2017Pee Hwee, Pang +1 more
openaire +2 more sources
Severe eosinophilic asthma and mepolizumab
The Lancet Respiratory Medicine, 2016openaire +2 more sources